Bioactive Compounds
-
B7029 GavestinelSummary: NMDA receptor antagonist -
B7507 UK 78282 hydrochlorideSummary: KV1.3 and KV1.4 voltage-gated potassium channel blocker -
A3883 TonabersatSummary: Gap junction modulator,novel benzopyran compound for Migraine and epilepsy treatment -
BA2398 Boc-NH-PEG4-CH2CH2NH2Summary: Can be used for the synthesis of antibody-coupled reactive molecules (ADCs). -
SL1062 Ritonavir-13CD3Summary: 13C- and deuterium-labeled Ritonavir -
C8406 LomedeucitinibSummary: Lomedeucitinib (BMS-986322) acts by targeting receptor tyrosine protein kinases. -
A9911 4-Aminobenzamidine dihydrochlorideSummary: A protease inhibitor -
B8002 LY2857785Summary: CDK9 inhibitor -
B6091 GSK-J1 sodium salt1 Citation -
B7815 NSC228155Summary: EGFR activator

